Lung Diseases, Obstructive  >>  timapiprant (OC000459)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
timapiprant (OC000459) / Chiesi
NCT01056692 / 2005-005838-12: OC000459 Bronchial Allergen Challenge

Completed
2
20
Europe
OC000459, Placebo
Oxagen Ltd, Medicines Evaluation Unit, Manchester, UK, King's College Hospital NHS Trust
Bronchial Asthma
 
 
NCT00890877 / 2008-006013-24: OC000459 Dose Finding Study in Patients With Mild to Moderate Persistent Asthma

Completed
2
480
Europe, RoW
OC000459 or placebo
Oxagen Ltd
Mild to Moderate Persistent Asthma
05/10
07/10

Download Options